Emerging targeted and cellular therapies in the treatment of advanced and metastatic synovial sarcoma

Synovial sarcoma is a soft tissue sarcoma accounting for approximately 1,000 cases per year in the United States. Currently, standard treatment of advanced and metastatic synovial sarcoma is anthracycline-based chemotherapy. While advanced synovial sarcoma is more responsive to chemotherapy compared...

Descripción completa

Detalles Bibliográficos
Autores principales: Fuchs, Joseph R., Schulte, Brian C., Fuchs, Jeffrey W., Agulnik, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905840/
https://www.ncbi.nlm.nih.gov/pubmed/36761952
http://dx.doi.org/10.3389/fonc.2023.1123464

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905840/
https://www.ncbi.nlm.nih.gov/pubmed/36761952
http://dx.doi.org/10.3389/fonc.2023.1123464

Ejemplares similares